Figures & data
Table 1 Indications and contraindications of treatment options for small renal massesCitation31
Table 2 Major drugs suspected of potential drug interaction with targeted agents
Table 3 Algorithm for systemic treatment in metastatic renal cell carcinomaCitation30
Table 4 Summary of the phase III trials for approved agents with median age and oldest patient
Table 5 Specific considerations for the elderly at each stage of patient treatment